ZÁZNAM | Proběhlo Pá, 13.3.2026
Webinář Peptide 360, epizoda 2, věnovaný integrovaným LC-MS a informatickým pracovním postupům pro vývoj a kontrolu životního cyklu terapeutik GLP-1 a peptidů.Přejít na webinář
Designing Integrated Analytical Workflows for GLP-1 and Peptide Therapeutics
Agilent Technologies: Peptide 360: Mastering the Invisible from Sequence to Confidence
A five-part webinar series unlocking advanced insights across the Peptide therapeutics workflows
Peptide therapeutics are reshaping modern medicine, with GLP-1 receptor agonists driving rapid advances in metabolic disease treatment. As peptide and GLP-1 programs scale, scientists face increasing pressure to generate data that is accurate, defensible, and decision-ready across development stages.
Peptide 360 is designed to guide scientists through this complexity, following the peptide workflow from sequence insight to confident development decisions.
Who Should Attend?
This series is designed for scientists and technical leaders working in peptide and GLP-1 discovery and development, analytical development, characterization, Bioanalysis, DMPK, translational research, CMC, QA/QC, and regulatory-facing analytical roles
How the Series Works?
- Register once for the full series
- Pre-submit questions for live expert responses
- Access recordings anytime after each session
- Certificate of attendance provided
Episode 2: Designing Integrated Analytical Workflows for GLP-1 and Peptide Therapeutics
The rapid expansion of peptide therapeutics, led by GLP-1 agonists, is increasing the need for analytical workflows that extend beyond individual techniques. Successful peptide development depends on designing integrated workflows that connect method development, characterization, and quality control across the lifecycle.
This session explores how such workflows are enabled through the combination of complementary separation technologies, mass spectrometry, and informatics within Agilent’s integrated analytical ecosystem. Attendees will gain insight into how end-to-end integration, from data generation to data management, supports consistent, compliant, and decision-ready peptide analysis as programs scale from research to manufacturing.
Presenter: Lauren Skrajewski-Schuler, Ph.D. (Biopharma Workflow Specialist, Agilent Technologies, Inc.)
Presenter: Ashish Pargaonkar, Ph.D. (Biopharma Applications Specialist, Agilent Technologies, Inc.)
